ANDA 207651, held by Alkem Labs Ltd. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 207651 (Triamcinolone Acetonide), held by Alkem Labs Ltd, was first approved by FDA on Dec 26, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 26, 2017 | Original application | Approved | None posted |
| Triamcinolone Acetonide0.025% · cream;topical | Triamcinolone Acetonide | Rx |
| Triamcinolone Acetonide0.1% · cream;topical | Triamcinolone Acetonide | Rx |
| Triamcinolone Acetonide0.5% · cream;topical | Triamcinolone Acetonide | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
